drugset / Trial / NCT00351754

Detection of Pulmonary Embolism With CECT

NCT00351754

Phase 4 Completed 120 enrolled Bracco Diagnostics, Inc
RandomizedParallel-groupDouble-blindDiagnostic

Summary

To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA

Timeline

Start
2006-07
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Iopamidol Diagnostic / imaging agent

Indications